ADAM17 and breast carcinoma: ADAM17 promotes cleavage of PD-L1 on the surface of breast cancer cells (12), regulates the interaction between PD-L1 and PD-1 (12), and may contribute to immune escape of triple-negative breast cancer cells (12, 202).